SANA
Sana Biotechnology IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$856.64M
P/E Ratio
—
EPS
$-0.96
Beta
2.06
52W High
$6.55
52W Low
$1.49
50-Day MA
$3.71
200-Day MA
$3.95
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Sana Biotechnology Inc
Sana Biotechnology, Inc., a biotechnology company, focuses on the use of modified cells as medicines. The company is headquartered in Seattle, Washington.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-178.21M |
| Operating Margin | 0.00% |
| Return on Equity | -118.70% |
| Return on Assets | -26.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.60 |
| Price-to-Book | 5.31 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -1.08 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $266.87M |
| Float | $177.28M |
| % Insiders | 7.02% |
| % Institutions | 77.28% |
Analyst Ratings
Consensus ($8.43 target)
2
Strong Buy6
Buy1
HoldData last updated: 4/9/2026